Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-26

Clinical Trial Update: Immediate Release Torsemide Versus Extended Release Torsemide After Salty Meal [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing immediate-release torsemide versus extended-release torsemide after a salty meal in heart failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Torsemide (torsemide)

Snippet

Sponsor: Sarfez Pharmaceuticals, Inc. | Conditions: Heart Failure | Phase 2 | Status: TERMINATED